BridgeMD
New treatment option for Cryopreservation
Official title Improving the Quality of Cryopreserved Ovarian Tissue Reimplantation Using Platelet-enriched Autologous Plasma
ClinicalTrials.gov ID: NCT06261658
What this study is testing
- What it's testing
- The study is aimed to evaluate the effects of intraovarian injection of autologous Platelet-enriched Autologous Plasma on the outcomes of orthotopic transplantation of cryopreserved ovarian tissue.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults, women only
You may be able to join if
- request for cryopreserved ovarian tissue transplantation;
- premature ovarian failure or irregular mentrual cycles;
- negative test for HIV, HBV, HCV, Treponema pallidum;
- negative PAP test;
- oncological authorization;
You likely can't join if
- neoplastic contamination in cryopreserved ovarian tissue;
- history of endometriosis;
- endocrinological disorders present and not treated (uncompensated thyroid dysfunction, diabetes (type 1, type 2);
- body mass index (BMI) \>30 kg/m2;
- circulating platelet level \< 150,000 / mml;
- bacterial infection;
See the full eligibility criteria
- request for cryopreserved ovarian tissue transplantation;
- premature ovarian failure or irregular mentrual cycles;
- negative test for HIV, HBV, HCV, Treponema pallidum;
- negative PAP test;
- oncological authorization;
- absence of neoplastic contamination in the cryopreserved ovarian tissue;
- Informed consent
- neoplastic contamination in cryopreserved ovarian tissue;
- history of endometriosis;
- endocrinological disorders present and not treated (uncompensated thyroid dysfunction, diabetes (type 1, type 2);
- body mass index (BMI) \>30 kg/m2;
- circulating platelet level \< 150,000 / mml;
- bacterial infection;
- ongoing use of anticoagulants;
- bleeding diathesis.
The study team makes the final eligibility decision.
Where it's taking place
- Bologna, BO, Italy
Compensation & support
A stipend or compensation may be offered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bologna, BO, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.